American Society for Transplantation and Cellular Therapy names president
Click Here to Manage Email Alerts
Brenda M. Sandmaier, MD, has been named the 2022-2023 president of American Society for Transplantation and Cellular Therapy.
Sandmaier is professor in the clinical research division at Fred Hutchinson Cancer Research Center and professor of medicine in the division of medical oncology at University of Washington School of Medicine.
“The opportunity to serve as president of ASTCT is an honor," Sandmaier said in an association-issued press release. “My career has been focused on providing allogeneic transplantation immunotherapy to more patients with hematologic malignancies around the world, which is in line with the mission of ASTCT. With the ASTCT board of directors, I look forward to advancing science and education in this important and ever-evolving field of medicine.”
Sandmaier's research has focused on extending the benefits of transplant immunotherapy to a broader range of patients, including hematopoietic stem cell transplant patients who are older or have medical comorbidities, and those who do not have fully HLA-matched donors.
She has conducted trials designed to identify strategies to prevent graft-versus-host disease with different donor types. Her lab has developed less toxic conditioning regimens for patients with blood cancers and benign blood disorders.
The other members of ASTCT’s board of directors for 2022-2023 are president-elect Miguel-Angel Perales, MD, of Memorial Sloan Kettering Cancer Center; vice president Corey Cutler, MD, MPH, of Dana-Farber Cancer Institute; past president Stella Davies, MBBS, PhD, of Cincinnati Children's Hospital; secretary Amrita Krishnan, MD, of City of Hope; and treasurer Uday Popat, MD, MBA, of The University of Texas MD Anderson Cancer Center. The directors of community or clinical practice are Shalini Shenoy, MD, of St. Louis Children's Hospital; Betty Hamilton, MD, of Cleveland Clinic; and Nandita Khera, MD, MPH, of Mayo Clinic. The directors of laboratory science are Leslie Kean, MD, PhD, of Boston Children's Hospital; Brian Betts, MD, of University of Minnesota; and Alan Hanash, MD, PhD, of Memorial Sloan Kettering Cancer Center. Directors at large are Eneida Nemecek, MD, MS, MBA, of Oregon Health & Science University; Kirsten Williams, MD, of Emory University; and Lori Muffly, MD, MS, of Stanford University. Robert Korngold, PhD, is editor-in-chief of Transplantation and Cellular Therapy.
Click Here to Manage Email Alerts